Ramón Angel Durazo-Arvizú

Dr. Ramón Angel Durazo-Arvizú


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2016 in Nutrients
Verified
Journal Article
Open access
PDF file
COColette M. O’neill
Colette M. O’neill
AKAndreas Kazantzidis
Andreas Kazantzidis
MRMary J. Ryan
Mary J. Ryan
NBNiamh Barber
Niamh Barber
CSChristopher T. Sempos
Christopher T. Sempos
KCKevin Cashman
Kevin Cashman
Low vitamin D status is common in Europe. The major source of vitamin D in humans is ultraviolet B (UVB)-induced dermal synthesis of cholecalciferol, whereas food sources are believed to play a lesser role. Our objectives were to assess UVB availability (Jm−2) across several European locations ranging from 35° N to 69° N, and compare these UVB data with representative population serum 25-hydroxyvitamin D (25(OH)D) data from Ireland (51–54° N), Iceland (64° N) and Norway (69° N), as exemplars. Vitamin D-effective UVB availability was modelled for nine European countries/regions using a validated UV irradiance model. Standardized serum 25(OH)D data was accessed from the EC-funded ODIN project. The results showed that UVB availability decreased with increasing latitude (from 35° N to 69° N), while all locations exhibited significant seasonal variation in UVB. The UVB data suggested that the duration of vitamin D winters ranged from none (at 35° N) to eight months (at 69° N). The large seasonal fluctuations in serum 25(OH)D in Irish adults was much dampened in Norwegian and Icelandic adults, despite considerably lower UVB availability at these northern latitudes but with much higher vitamin D intakes. In conclusion, increasing the vitamin D intake can ameliorate the impact of low UVB availability on serum 25(OH)D status in Europe.

1 September 2014 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
RDRamón Angel Durazo-Arvizú
Ramón Angel Durazo-Arvizú
PCPauline Camacho
Pauline Camacho
PBPascal Bovet
Pascal Bovet
TFTerrence Forrester
Terrence Forrester
ELEstelle Lambert
Estelle Lambert
ALAmy Luke
Amy Luke
Background: The vitamin D–endocrine system is thought to play a role in physiologic processes that range from mineral metabolism to immune function.

6 July 2018 in BMC Public Health
Verified
Journal Article
Open access
PDF file
MRMartina Rabenberg
Martina Rabenberg
CSChrista Scheidt-Nave
Christa Scheidt-Nave
MBMarkus A. Busch
Markus A. Busch
MTMichael Thamm
Michael Thamm
NRNina Rieckmann
Nina Rieckmann
GMGert B. M. Mensink
Gert B. M. Mensink
Comparability of 25-hydroxyvitamin D (25(OH)D) measurements is hampered by method-related differences in measurement values. International standardization of laboratory assays has been suggested to solve this problem. As part of the European Commission–funded project ‘Food-based solutions for optimal vitamin D nutrition and health through the life cycle’ (ODIN), original measurements of serum 25(OH)D of three German national health surveys conducted between 1998 and 2011 have been standardized retrospectively. In these representative population-based samples including persons aged between 1 and 79 years, the original 25(OH)D values were compared with those after standardization. Mean values and prevalences of vitamin D deficiency, insufficiency, and sufficiency (25(OH)D levels < 30, 30- < 50, and > =50 nmol/l, respectively) were calculated by sex and age groups based on original and standardized 25(OH)D data. In comparison to the original 25(OH)D levels, the standardized levels showed higher means overall and in age- and sex-specific analyses. After standardization, the prevalence of vitamin D deficiency was lower in all surveys while the prevalence of vitamin D sufficiency was higher. Nevertheless, even after standardization ~ 15% of adults and 12.5% of children had serum 25(OH)D levels < 30 nmol/l. Thus, the proportion of deficient vitamin D levels in the German population is still considerable. The use of standardization of 25(OH)D levels has a substantial impact on estimates of the vitamin D status in Germany. Since clinical diagnostic, therapeutic and public health decision-making require valid and comparable data, standardization and calibration of commercial, clinical and research laboratory assays for 25(OH)D measurement should become common practice. Until then, researchers, health practitioners and policy makers should be aware of the peculiarities of the measurement methods when comparing and interpreting 25(OH)D levels.

15 March 2017 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
RDRamón Angel Durazo-Arvizú
Ramón Angel Durazo-Arvizú
BDBess Dawson-Hughes
Bess Dawson-Hughes
HKHolly Kramer
Holly Kramer
GCGuichan Cao
Guichan Cao
JMJoyce Merkel
Joyce Merkel
CSChristopher T. Sempos
Christopher T. Sempos
We evaluated the impact of standardizing the originally measured serum total 25-hydroxyvitamin D (25(OH)D) values from Third National Health and Nutrition Examination Survey (NHANES III, 1988–1994) on the association between 25(OH)D and rate of all-cause mortality. Values were standardized to the gold-standard laboratory method. Follow-up from 1990–2006 consisted of 15,099 participants aged at least 20 years at baseline, among whom there were 3,784 deaths. Relative risk of death was adjusted for age, sex, race/ethnicity, and season using Poisson regression. Results were obtained for eight 25(OH)D (nmol/L) categories: <20 nmol/L, 20–29 nmol/L, 30–39 nmol/L, 40–49 nmol/L, 50–59 nmol/L, 60–74 nmol/L, 75–99 nmol/L (reference), and ≥100 nmol/L. Assay standardization dramatically shifted original 25(OH)D values toward zero. Accordingly, risk ≥120 nmol/L could not be evaluated (i.e., n = 7 and ndeaths = 2). Relative risk (95% confidence interval (CI)) <40 nmol/L remained significant (30–39 nmol/L: relative risk (RR) = 1.4 (95% CI: 1.1, 1.6); 20–29 nmol/L: RR = 1.6 (95% CI: 1.3, 1.9), and <20 nmol/L: RR = 2.1 (95% CI: 1.6, 2.7). However, adjusted relative risk estimates for 25(OH)D levels ≥40 nmol/L were no longer significant (40–49 nmol/L: RR = 1.2 (95% CI: 0.99, 1.4); 50–59 nmol/L: RR = 1.2 (95% CI: 1.04, 1.4); 60–74 nmol/L: RR = 1.1 (95% CI: 0.94, 1.2); 75–99 nmol/L: RR = 1.0 (referent), and ≥100 nmol/L: RR = 1.1 (95% CI: 0.6, 2.1). In summary, after standardization, risk of death from all causes increased with decreasing 25(OH)D <40 nmol/L, while there was no association with values in categories between 40 nmol/L and 120 nmol/L.

24 April 2014 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ALAmy Luke
Amy Luke
Pascal BovetPascal Bovet
Pascal Bovet
JPJacob Plange-Rhule
Jacob Plange-Rhule
TFTerrence Forrester
Terrence Forrester
ELEstelle Lambert
Estelle Lambert
RCRichard S Cooper
Richard S Cooper
Examination of patterns and intensity of physical activity (PA) across cultures where obesity prevalence varies widely provides insight into one aspect of the ongoing epidemiologic transition. The primary hypothesis being addressed is whether low levels of PA are associated with excess weight and adiposity. We recruited young adults from five countries (500 per country, 2500 total, ages 25–45 years), spanning the range of obesity prevalence. Men and women were recruited from a suburb of Chicago, Illinois, USA; urban Jamaica; rural Ghana; peri-urban South Africa; and the Seychelles. PA was measured using accelerometry and expressed as minutes per day of moderate-to-vigorous activity or sedentary behavior. Obesity (BMI ≥ 30) prevalence ranged from 1.4% (Ghanaian men) to 63.8% (US women). South African men were the most active, followed by Ghanaian men. Relatively small differences were observed across sites among women; however, women in Ghana accumulated the most activity. Within site-gender sub-groups, the correlation of activity with BMI and other measures of adiposity was inconsistent; the combined correlation across sites was -0.17 for men and -0.11 for women. In the ecological analysis time spent in moderate-to-vigorous activity was inversely associated with BMI (r = -0.71). These analyses suggest that persons with greater adiposity tend to engage in less PA, although the associations are weak and the direction of causality cannot be inferred because measurements are cross-sectional. Longitudinal data will be required to elucidate direction of association.

9 September 2016 in BMC Public Health
Verified
Journal Article
Open access
PDF file
VRViviane Richard
Viviane Richard
TFTerrence Forrester
Terrence Forrester
JPJacob Plange-Rhule
Jacob Plange-Rhule
ELEstelle Lambert
Estelle Lambert
BVBharathi Viswanathan
Bharathi Viswanathan
Pascal BovetPascal Bovet
Pascal Bovet
Associations between socioeconomic status (SES) and risk factors for noncommunicable diseases (NCD-RFs) may differ in populations at different stages of the epidemiological transition. We assessed the social patterning of NCD-RFs in a study including populations with different levels of socioeconomic development. Data on SES, smoking, physical activity, body mass index, blood pressure, cholesterol and glucose were available from the Modeling the Epidemiologic Transition Study (METS), with about 500 participants aged 25–45 in each of five sites (Ghana, South Africa, Jamaica, Seychelles, United States). The prevalence of NCD-RFs differed between these populations from five countries (e.g., lower prevalence of smoking, obesity and hypertension in rural Ghana) and by sex (e.g., higher prevalence of smoking and physical activity in men and of obesity in women in most populations). Smoking and physical activity were associated with low SES in most populations. The associations of SES with obesity, hypertension, cholesterol and elevated blood glucose differed by population, sex, and SES indicator. For example, the prevalence of elevated blood glucose tended to be associated with low education, but not with wealth, in Seychelles and USA. The association of SES with obesity and cholesterol was direct in some populations but inverse in others. In conclusion, the distribution of NCD-RFs was socially patterned in these populations at different stages of the epidemiological transition, but associations between SES and NCD-RFs differed substantially according to risk factor, population, sex, and SES indicator. These findings emphasize the need to assess and integrate the social patterning of NCD-RFs in NCD prevention and control programs in LMICs.